GSK's China sales may be down 30% on bribery scandal
Updated: 2013-09-24 10:56
(Agencies)
|
|||||||||
GlaxoSmithKline's sales in China may have dropped 30 percent since authorities accused it of corruption, disrupting its ability to market medicines in the country, according to analyst estimates.
Citigroup said initial feedback following the accusations against GSK and investigations into other firms suggested that sales of some multinational drug companies were down as much as 30 percent or more in volume terms since June.
A Chinese national flag flutters in front of a GlaxoSmithKline (GSK) office building in Shanghai July 12, 2013. [Photo / Agencies] |
Industry insiders told Reuters last week that GSK, which is at the center of the furor, had suffered more damage than its peers as many Chinese hospital doctors refuse to see sales staff and promotional activities are curtailed.
GSK has said some of its senior Chinese executives appeared to have broken the law after police accused it of funneling up to 3 billion yuan ($490 million) to travel agencies to facilitate bribes to doctors to boost sales of its medicines.
Britain's biggest drugmaker has declined to detail the impact of the scandal on its business but a spokesman said the company was seeing "some impact" as a result of the ongoing Chinese investigations.
GSK generated a modest 3.6 percent of its global drug sales in China last year but sees the country as an important source of future revenue.
Citigroup said in a research note dated Sept 17 that multinational drugmakers might need to review current sales models, which rely heavily on expanding large sales forces, and could face pricing pressure on their off-patent drugs.
- China's growth: Fundamental challenges still remain
- Microsoft revamps Surface to challenge Apple
- Beijing seeks greater cooperation in space
- Panda cubs make debut during National holiday
- VIVA SALSA!
- 'Breaking Bad,' 'Modern Family' crowned at Emmys
- Obama attends Navy Yard shooting memorial
- Typhoon Usagi kills 25 in China
Most Viewed
Editor's Picks
Old soldiers receive badge of recognition |
The road to life after education |
New energy solutions |
Xinjiang scores on the national stage at last |
Watchdog bites with no favor |
Africa looks to the Orient for lessons |
Today's Top News
Microsoft shifts tablet plans for China
GSK's China sales may be down 30% on bribery scandal
China to help deal with chemical weapons
China, Africa 'share destiny'
Maryland, Xi'an seek new link
Trending news across China
China announces pricing policy for fuel upgrade
China to increase rare earth purchase
US Weekly
Geared to go |
The place to be |